BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Jacobs JFM, Bossuyt X. Standardization and harmonization of autoimmune diagnostics. Clin Chem Lab Med 2018;56:1563-7. [PMID: 30120908 DOI: 10.1515/cclm-2018-0807] [Cited by in Crossref: 12] [Cited by in F6Publishing: 17] [Article Influence: 4.0] [Reference Citation Analysis]
Number Citing Articles
1 Van Hoovels L, Studholme L, Vander Cruyssen B, Sieghart D, Bonroy C, Nagy E, Pullerits R, Čučnik S, Dahle C, Heijnen I, Bernasconi L, Benkhadra F, Bogaert L, Van Den Bremt S, Van Liedekerke A, Vanheule G, Robbrecht J, Wirth C, Müller R, Kyburz D, Sjöwall C, Kastbom A, Ješe R, Jovancevic B, Kiss E, Jacques P, Aletaha D, Steiner G, Verschueren P, Bossuyt X. Standardisation of ACPA tests: evaluation of a new candidate reference preparation. Ann Rheum Dis 2022:annrheumdis-2021-221849. [PMID: 35697487 DOI: 10.1136/annrheumdis-2021-221849] [Reference Citation Analysis]
2 Van Hoovels L, Vander Cruyssen B, Sieghart D, Bonroy C, Nagy E, Pullerits R, Čučnik S, Dahle C, Heijnen I, Bernasconi L, Benkhadra F, Bogaert L, Van Den Bremt S, Van Liedekerke A, Vanheule G, Robbrecht J, Studholme L, Wirth C, Müller R, Kyburz D, Sjöwall C, Kastbom A, Ješe R, Jovancevic B, Kiss E, Jacques P, Aletaha D, Steiner G, Verschueren P, Bossuyt X. Multicentre study to improve clinical interpretation of rheumatoid factor and anti-citrullinated protein/peptide antibodies test results. RMD Open 2022;8:e002099. [PMID: 35321875 DOI: 10.1136/rmdopen-2021-002099] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
3 Bonroy C, Piette Y, Allenbach Y, Bossuyt X, Damoiseaux J. Positioning of myositis-specific and associated autoantibody (MSA/MAA) testing in disease criteria and routine diagnostic work-up. Journal of Translational Autoimmunity 2022. [DOI: 10.1016/j.jtauto.2022.100148] [Reference Citation Analysis]
4 Van Hoovels L, Studenic P, Sieghart D, Steiner G, Bossuyt X, Rönnelid J. Impact of autoimmune serology test results on RA classification and diagnosis. J Transl Autoimmun 2022;5:100142. [PMID: 35036891 DOI: 10.1016/j.jtauto.2022.100142] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
5 Veenbergen S, Kozmar A, van Daele PLA, Schreurs MWJ. Autoantibodies in Sjögren's syndrome and its classification criteria. J Transl Autoimmun 2022;5:100138. [PMID: 35024595 DOI: 10.1016/j.jtauto.2021.100138] [Reference Citation Analysis]
6 Orme ME, Voreck A, Aksouh R, Schreurs MWJ. Anti-dsDNA Testing Specificity for Systemic Lupus Erythematosus: A Systematic Review. J Appl Lab Med 2022;7:221-39. [PMID: 34996090 DOI: 10.1093/jalm/jfab146] [Reference Citation Analysis]
7 Mahler M, Malyavantham K, Seaman A, Bentow C, Anunciacion-Llunell A, Sanz-Martínez MT, Viñas-Gimenez L, Selva-O'Callaghan A. Profiling of Myositis Specific Antibodies and Composite Scores as an Aid in the Differential Diagnosis of Autoimmune Myopathies. Diagnostics (Basel) 2021;11:2246. [PMID: 34943483 DOI: 10.3390/diagnostics11122246] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
8 Rönnelid J, Turesson C, Kastbom A. Autoantibodies in Rheumatoid Arthritis - Laboratory and Clinical Perspectives. Front Immunol 2021;12:685312. [PMID: 34054878 DOI: 10.3389/fimmu.2021.685312] [Cited by in F6Publishing: 13] [Reference Citation Analysis]
9 Tešija Kuna A, Đerek L, Drvar V, Kozmar A, Gugo K. Assessment of antinuclear antibodies (ANA): National recommendations on behalf of the Croatian society of medical biochemistry and laboratory medicine. Biochem Med (Zagreb) 2021;31:020502. [PMID: 33927550 DOI: 10.11613/BM.2021.020502] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
10 Cinquanta L, Bizzaro N, Pesce G. Standardization and Quality Assessment Under the Perspective of Automated Computer-Assisted HEp-2 Immunofluorescence Assay Systems. Front Immunol 2021;12:638863. [PMID: 33717188 DOI: 10.3389/fimmu.2021.638863] [Cited by in F6Publishing: 4] [Reference Citation Analysis]
11 Richards M, García-De La Torre I, González-Bello YC, Vázquez-Del Mercado M, Andrade-Ortega L, Medrano-Ramírez G, Navarro-Zarza JE, Maradiaga-Ceceña M, Loyo E, Rojo-Mejía A, Gómez G, Seaman A, Fritzler MJ, Koenig M, Mahler M. Autoantibodies to Mi-2 alpha and Mi-2 beta in patients with idiopathic inflammatory myopathy. Rheumatology (Oxford) 2019;58:1655-61. [PMID: 30938432 DOI: 10.1093/rheumatology/kez092] [Cited by in Crossref: 9] [Cited by in F6Publishing: 13] [Article Influence: 4.5] [Reference Citation Analysis]
12 Damoiseaux J. The perspective on standardisation and harmonisation: the viewpoint of the EASI president. Auto Immun Highlights 2020;11:4. [PMID: 32127033 DOI: 10.1186/s13317-020-0127-3] [Cited by in Crossref: 9] [Cited by in F6Publishing: 13] [Article Influence: 4.5] [Reference Citation Analysis]
13 Benveniste O, Goebel HH, Stenzel W. Biomarkers in Inflammatory Myopathies-An Expanded Definition. Front Neurol 2019;10:554. [PMID: 31214105 DOI: 10.3389/fneur.2019.00554] [Cited by in Crossref: 16] [Cited by in F6Publishing: 21] [Article Influence: 5.3] [Reference Citation Analysis]
14 Choi MY, Fritzler MJ. Challenges and Advances in SLE Autoantibody Detection and Interpretation. Curr Treat Options in Rheum 2019;5:147-67. [DOI: 10.1007/s40674-019-00122-0] [Cited by in Crossref: 9] [Article Influence: 3.0] [Reference Citation Analysis]
15 Mahler M, Betteridge Z, Bentow C, Richards M, Seaman A, Chinoy H, McHugh N. Comparison of Three Immunoassays for the Detection of Myositis Specific Antibodies. Front Immunol 2019;10:848. [PMID: 31114570 DOI: 10.3389/fimmu.2019.00848] [Cited by in Crossref: 23] [Cited by in F6Publishing: 34] [Article Influence: 7.7] [Reference Citation Analysis]
16 Dellavance A, Baldo DC, Zheng B, Mora RA, Fritzler MJ, Hiepe F, Rönnelid J, Satoh M, Garcia-de La Torre I, Wener MH, Chan EK, Andrade LE. Establishment of an international autoantibody reference standard for human anti-DFS70 antibodies: proof-of-concept study for a novel Megapool strategy by pooling individual specific sera. Clinical Chemistry and Laboratory Medicine (CCLM) 2019;57:1754-63. [DOI: 10.1515/cclm-2019-0087] [Cited by in Crossref: 8] [Cited by in F6Publishing: 10] [Article Influence: 2.7] [Reference Citation Analysis]
17 Van Hoovels L, Bossuyt X. Harmonisation of laboratory tests for rheumatic diseases: still a long way to go. Ann Rheum Dis 2020;79:e5. [PMID: 30514700 DOI: 10.1136/annrheumdis-2018-214696] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]